An Inca trail to the Holy Grail: digital medication adherence support for TB care

Affiliations

¹ Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands, Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands.
² Department of Pharmacy, Westmead Hospital, Sydney, NSW, Australia, Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia, Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, NSW, Australia.

Editorial

J F M van Boven et al. Int J Tuberc Lung Dis. 2022.

. 2022 Jan 1;26(1):1-3.

doi: 10.5588/ijtld.21.0613.

¹ Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands, Medication Adherence Expertise Center of the northern Netherlands (MAECON), Groningen, The Netherlands.
² Department of Pharmacy, Westmead Hospital, Sydney, NSW, Australia, Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, NSW, Australia, Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney, Sydney, NSW, Australia.

No abstract available

Comment in

After DOT, the brave new world?
Noeske J, Kuaban C. Noeske J, et al. Int J Tuberc Lung Dis. 2022 Apr 1;26(4):379-380. doi: 10.5588/ijtld.22.0037. Int J Tuberc Lung Dis. 2022. PMID: 35351247 No abstract available.
Digital medication adherence technology: towards personalised TB care.
van Boven JFM, Alffenaar JC. van Boven JFM, et al. Int J Tuberc Lung Dis. 2022 Apr 1;26(4):380-381. doi: 10.5588/ijtld.22.0067. Int J Tuberc Lung Dis. 2022. PMID: 35351248 No abstract available.